No Data
No Data
MIRA Pharmaceuticals | 10-Q: Quarterly report
MIRA Pharmaceuticals Sees Positive Trial Results for Ketamir-2
By Chris Wack MIRA Pharmaceuticals said it saw positive results in its trial for Ketamir-2, a novel oral ketamine analog that could potentially deliver ultra-rapid antidepressant effects. The pre-cl
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersMSP Recovery (NASDAQ:LIFW) stock increased by 61.9% to $1.08 during Tuesday's pre-market session. The company's market cap stands at $15.9 million. Serina Therapeutics (AMEX:SER) stock moved up
Express News | Mira Pharmaceuticals Highlights Preclinical Ketamir-2 Updates; Says Is Hopeful Results Will Enable Co. To File An NDA With FDA By End Of This Year
Express News | Mira Pharmaceuticals Q4 EPS $(0.19) Beats $(0.23) Estimate
GOEV, CHEK and MESO Among Pre-market Losers
No Data